Your browser doesn't support javascript.
loading
Outcomes of transplant-eligible patients with myelodysplastic syndrome with excess blasts registered in an observational study: The JALSG-CS11-MDS-SCT.
Nakagawa, Noriharu; Ishiyama, Ken; Usuki, Kensuke; Takada, Satoru; Tomikawa, Tatsuki; Handa, Hiroshi; Katsuoka, Yuna; Hirano, Daiki; Sezaki, Nobuo; Sumi, Masahiko; Fujisawa, Shin; Taniguchi, Yasuhiro; Mugitani, Atsuko; Yoshimura, Takuro; Ohtsuka, Eiichi; Takase, Ken; Suehiro, Youko; Ota, Shuichi; Kajiguchi, Tomohiro; Maeda, Tomoya; Yamamoto, Masahide; Ohtake, Shigeki; Katsumi, Akira; Kiyoi, Hitoshi; Matsumura, Itaru; Miyazaki, Yasushi.
Afiliação
  • Nakagawa N; Department of Internal Medicine, Keiju Medical Center, Nanao, Japan.
  • Ishiyama K; Department of Hematology, Kanazawa University Hospital, Kanazawa, Japan.
  • Usuki K; Department of Hematology, Kanazawa University Hospital, Kanazawa, Japan. ishiyama-knz@umin.ac.jp.
  • Takada S; Department of Hematology, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku, Tokyo, 162-8655, Japan. ishiyama-knz@umin.ac.jp.
  • Tomikawa T; Department of Hematology, NTT Medical Center Tokyo, Shinagawa, Japan.
  • Handa H; Leukemia Research Center, Saiseikai Maebashi Hospital, Maebashi, Japan.
  • Katsuoka Y; Department of Hematology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
  • Hirano D; Department of Hematology, Gunma University Hospital, Maebashi, Japan.
  • Sezaki N; Department of Hematology, Sendai Medical Center, National Hospital Organization, Sendai, Japan.
  • Sumi M; Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Fujisawa S; Department of Hematology, Chugoku Central Hospital, Miyukichokamiiwanari, Japan.
  • Taniguchi Y; Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan.
  • Mugitani A; Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
  • Yoshimura T; Department of Hematology and Rheumatology, Kindai University Hospital, Osakasayama, Japan.
  • Ohtsuka E; Department of Hematology, Fuchu Hospital, Izumi, Japan.
  • Takase K; Department of Hematology, Osaka City General Hospital, Osaka, Japan.
  • Suehiro Y; Department of Hematology, Oita Prefectural Hospital, Oita, Japan.
  • Ota S; Department of Hematology, Kyushu Medical Center, Fukuoka, Japan.
  • Kajiguchi T; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Maeda T; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
  • Yamamoto M; Department of Hematology and Oncology, Tosei General Hospital, Seto, Japan.
  • Ohtake S; Department of Hemato-Oncology, Saitama International Medical Center, Saitama Medical University, Hidaka, Japan.
  • Katsumi A; Department of Hematology, Tokyo Medical and Dental University, Bunkyo, Japan.
  • Kiyoi H; Department of Hematology, Kanazawa University Hospital, Kanazawa, Japan.
  • Matsumura I; Department of Hematology, National Center for Geriatrics and Gerontology, Obu, Japan.
  • Miyazaki Y; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ann Hematol ; 103(1): 307-320, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37940714

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Transplante de Células-Tronco Hematopoéticas Limite: Aged / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Transplante de Células-Tronco Hematopoéticas Limite: Aged / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article